HomeArticles › WADA & fair play
Fair play · 5 min read

Is Ozempic allowed in competition? WADA & fair play

If you race — from age-group triathlon to masters road cycling — and you're on a GLP-1, one question comes up fast: is this allowed? Here's the honest, current picture.

The short answer: not banned, but watched

As of 2026, GLP-1 medications like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are not on the WADA Prohibited List — they're permitted in and out of competition, and no Therapeutic Use Exemption is required simply for using one. However, WADA placed these on its Monitoring Program (semaglutide markers earlier, tirzepatide added January 1, 2026). "Monitored" means WADA is tracking patterns of use across elite sport to decide whether the status should change — not that it's banned.

Not prohibited today. Actively watched. Treat the status as a living thing, not a settled rule.

Why it's on the radar at all

WADA evaluates substances against three tests: performance enhancement, health risk, and the "spirit of sport." GLP-1s clearly change body composition, and there's concern about pharmacological stacking — some people combining them with genuinely banned substances (like anabolic steroids or SARMs) to offset muscle loss. That combination is what draws scrutiny, and it's both against the rules and a real health risk. Our whole point is the opposite: protect muscle with food and training, not more chemistry.

What to actually do

The fair-play mindset

Most people reading this aren't chasing a podium — they're a 45-year-old trying to finish a first 70.3 without falling apart. Using a prescribed medication for health, then training and eating to keep your strength, is squarely within the rules and the spirit of sport. Just stay informed, stay documented, and don't cut corners.

Read the science   Level-3 protocol builder →